Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy
Therapeutic Apheresis and Dialysis · 2024
DOI: 10.1111/1744-9987.14060 ↗Kurz gefasst
Leserbrief in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Michel Jadoul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
ORCID-Profile: Michel Jadoul
Zitieren
APA
Jadoul, M., & Labriola, L. (2024). Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14060
Vancouver
Jadoul M, Labriola L. Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14060
BibTeX
@article{Jadoul2024,
author = {Jadoul, Michel and Labriola, Laura},
title = {Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy},
journal = {Therapeutic Apheresis and Dialysis},
year = {2024},
doi = {10.1111/1744-9987.14060}
}
EUVIMED